0001127602-12-014165.txt : 20120418 0001127602-12-014165.hdr.sgml : 20120418 20120418163344 ACCESSION NUMBER: 0001127602-12-014165 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120417 FILED AS OF DATE: 20120418 DATE AS OF CHANGE: 20120418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FITZGERALD EDWARD M CENTRAL INDEX KEY: 0001242993 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 12766297 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-04-17 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001242993 FITZGERALD EDWARD M C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 Executive VP, CFO Common Stock 2012-04-17 4 M 0 40000 4.63 A 209548 D Common Stock 2012-04-17 4 S 0 40000 15.00 D 169548 D Employee Stock Option (Right to Buy) 4.63 2012-04-17 4 M 0 40000 0 D 2003-05-06 2012-05-06 Common Stock 40000 60000 D Shares were acquired upon the exercise of outstanding stock options at $4.63 per share. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011. /s/Edward M. Fitzgerald 2012-04-18